ActiTrexx GmbH | Finanzwire

Basculer en Français

11118	Companies
244800	Keywords
172882	Articles
131990	Press releases

Home
Companies
ActiTrexx GmbH

BRIEF

published on 10/20/2025 at 10:05, 11 months 14 days ago

ActiTrexx Completes Final Patient Treatment in GvHD Therapy Study

Clinical Study Graft-versus-Host Disease Actileucel Immune Therapy Regulatory T Cells
PRESS RELEASE

published on 10/20/2025 at 10:00, 11 months 14 days ago

ActiTrexx completes treatment of last patient with novel regulatory T cell therapy against Graft-versus-Host Disease
ActiTrexx completes treatment of last patient with novel regulatory T cell therapy against Graft-versus-Host Disease. Phase Ib/II study evaluates Actileucel for GvHD prevention

ActiTrexx Graft-versus-Host Disease Regulatory T Cell Therapy Actileucel Phase Ib/II Study
BRIEF

published on 03/19/2024 at 10:05, 2 years 6 months ago

ActiTrexx Initiates Treatment in Graft-versus-Host Disease Study with Novel T Cell Therapy

Clinical Study ActiTrexx Graft-versus-Host Disease Regulatory T Cell Therapy Actileucel
PRESS RELEASE

published on 03/19/2024 at 10:00, 2 years 6 months ago

ActiTrexx treats first patient with novel regulatory T cell therapy against Graft-versus-Host Disease
ActiTrexx GmbH treats first patient with novel regulatory T cell therapy for Graft-versus-Host Disease. Phase Ib/II study evaluates safety and feasibility of Actileucel treatment

Graft-versus-Host Disease Regulatory T Cell Therapy Actileucel ActiTrexx GmbH Phase Ib/II Study

Accesswire

Published on 10/03/2026 at 02:35, 7 hours 30 minutes ago

Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 17:45, 16 hours 20 minutes ago

Sparton Provides Status Update
Published on 10/02/2026 at 13:50, 20 hours 15 minutes ago

AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 21 hours 5 minutes ago

Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 21 hours 5 minutes ago

Alaska Energy Metals Appoints Independent Director, Thomas Benson

View all ACCESSWIRE

EQS Group

Published on 10/02/2026 at 23:55, 10 hours 9 minutes ago

IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 13 hours 41 minutes ago

EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 14 hours 18 minutes ago

innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 18:00, 16 hours 5 minutes ago

EQS-Adhoc: AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)
Published on 10/02/2026 at 18:00, 16 hours 5 minutes ago

AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)

Les Echos

Published on 10/02/2026 at 17:45, 16 hours 20 minutes ago

Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:30, 16 hours 35 minutes ago

Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/01/2026 at 19:00, 1 day 15 hours ago

AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 18:40, 1 day 15 hours ago

Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:05, 1 day 16 hours ago

Covivio - Information on total number of voting rights and share capital

View all LES ECHOS COMFI WIRE